DK1516061T3 - Fremgangsmåde til identificering af agonister eller antagonister for GPR45like/GPR63-receptoren - Google Patents

Fremgangsmåde til identificering af agonister eller antagonister for GPR45like/GPR63-receptoren

Info

Publication number
DK1516061T3
DK1516061T3 DK03740154T DK03740154T DK1516061T3 DK 1516061 T3 DK1516061 T3 DK 1516061T3 DK 03740154 T DK03740154 T DK 03740154T DK 03740154 T DK03740154 T DK 03740154T DK 1516061 T3 DK1516061 T3 DK 1516061T3
Authority
DK
Denmark
Prior art keywords
gpr45like
antagonists
identifying agonists
gpr63 receptor
gpr63
Prior art date
Application number
DK03740154T
Other languages
English (en)
Inventor
Johann Gassenhuber
Evi Kostenis
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1516061T3 publication Critical patent/DK1516061T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4719—G-proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK03740154T 2002-06-08 2003-05-28 Fremgangsmåde til identificering af agonister eller antagonister for GPR45like/GPR63-receptoren DK1516061T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10225651A DE10225651A1 (de) 2002-06-08 2002-06-08 Verfahren zur Identifizierung von Agonisten oder Antagonisten für den GPR45like/GPR63 Rezeptor
PCT/EP2003/005600 WO2003104480A1 (de) 2002-06-08 2003-05-28 Verfahren zur identifizierung von agonisten oder antagonisten für den gpr45like/gpr63 rezeptor

Publications (1)

Publication Number Publication Date
DK1516061T3 true DK1516061T3 (da) 2009-01-19

Family

ID=29594349

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03740154T DK1516061T3 (da) 2002-06-08 2003-05-28 Fremgangsmåde til identificering af agonister eller antagonister for GPR45like/GPR63-receptoren

Country Status (9)

Country Link
EP (1) EP1516061B1 (da)
JP (1) JP4472521B2 (da)
AT (1) ATE403738T1 (da)
AU (1) AU2003274087A1 (da)
CA (1) CA2488883A1 (da)
DE (2) DE10225651A1 (da)
DK (1) DK1516061T3 (da)
ES (1) ES2311102T3 (da)
WO (1) WO2003104480A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106544359B (zh) * 2015-09-22 2019-07-19 复旦大学 Gpr45基因的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138621A1 (de) * 1991-11-25 1993-06-17 Boehringer Ingelheim Int Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabhaengigen zellulaeren signaluebertragungsweg
WO1999024569A1 (fr) * 1997-11-11 1999-05-20 Ono Pharmaceutical Co., Ltd. Recepteur d'acide lysophosphatidique humain et utilisation dudit recepteur
US6126587A (en) * 1998-04-08 2000-10-03 U.S. Centrifuge Centrifugal separator apparatus including a plow blade assembly
AU4169499A (en) * 1998-06-22 2000-01-10 Japan Tobacco Inc. Novel g protein-coupled receptor protein, dna and use thereof
EP1196572A1 (en) * 1999-07-27 2002-04-17 Smithkline Beecham Plc Axor21, a g-protein coupled receptor
AU4926301A (en) * 2000-03-17 2001-10-03 Univ Tennessee Res Corp Lpa receptor agonists and antagonists and methods of use
WO2002034781A1 (en) * 2000-10-20 2002-05-02 Solvay Pharmaceuticals Gmbh Human g-protein coupled diadenosine tetraphosphate receptor (ap4ar)

Also Published As

Publication number Publication date
JP2005528920A (ja) 2005-09-29
ATE403738T1 (de) 2008-08-15
JP4472521B2 (ja) 2010-06-02
EP1516061A1 (de) 2005-03-23
WO2003104480A1 (de) 2003-12-18
ES2311102T3 (es) 2009-02-01
DE10225651A1 (de) 2003-12-24
AU2003274087A1 (en) 2003-12-22
EP1516061B1 (de) 2008-08-06
DE50310285D1 (de) 2008-09-18
CA2488883A1 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
DE60217147D1 (de) Lactamderivaten zur verwendung als humane 11cby rezeptorantagonisten
DK1891019T3 (da) 2,6-substituerede, 4-monosubstituerede aminopyrimidiner som prostaglandin-D2-receptorantagonister
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
NO20053340D0 (no) Substituerte dihydropyrano-indol-3,4-dion-derivater som inhibitorer for plasmigogenaktivator-1 (CPAI-1).
CY1109088T1 (el) Μεθοδος για την παρασκευη υποκατεστημενων ενωσεων 3-αρυλο-βουτυλ-αμινης
DK2308419T3 (da) Fremgangsmåde til bedømmelse af farvningstilstandene for dyresperm, som skal sorteres.
NO20034289D0 (no) N-(2-aryletylbenzylaminer som antagonister av 5-HT6- reseptoren
NO20062718L (no) Hjelpemiddel for angitt
DK2208727T3 (da) Diarylethere som opioidreceptorantagonister
DK1501826T3 (da) Substituerede indoler som alpha-1-agonister
NO20051970L (no) Fremgangsmate for fremstilling av valsartan og mellomprodukter for fremgangsmaten samt fremstilling derav.
DE60115653D1 (de) Verfahren zur Detektion von Emotionen, unter Verwendung von Untergruppenspezialisten
DK1778236T3 (da) Modificerede pyrimidin-glucocorticoid-receptor-modulatorer
ATE497492T1 (de) Reinigung von montelukast
ATE544870T1 (de) Profilierung einer rezeptorfamilie
NO20053335D0 (no) 2-aminokarbonyl-kinolinforbindelser som blodplateadenosindifosfatreseptorer.
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
CY1107368T1 (el) Νεα παραγωγα 4-βενζυλιδενο-πιπεριδινης
BRPI0417992A (pt) método para purificar fsh
NO20052415D0 (no) Fremgangsmate for gjeninntreden i en hovedbronnboring fra en lateral bronnboring, samt bunnhullssammenstilling for utfresing
NO20072293L (no) Lettvektsbyggeplate, samt fremgangsmate for tilvirkning av denne
NO20042198L (no) Tetrahydrokarbazolderivater som ligander for G-proteinkoplede reseptorer (GPCR).
NO20044373L (no) Azetidinderivater som CCR-3-reseptorantagonister
DK1511764T3 (da) Peptider og peptidomimetika, som er egnede til hæmning af aktiviteten af prostaglandin f2alfa-receptor
DK1516061T3 (da) Fremgangsmåde til identificering af agonister eller antagonister for GPR45like/GPR63-receptoren